bioMérieux files FDA application for rapid vaginitis diagnostic panel

Racura Oncology doses first patient in Phase 1 lung cancer trial

EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Oxford BioTherapeutics reports progress in Boehringer Ingelheim partnered programmes

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer

Transgene expands myvac platform into non-small cell lung cancer with TG4070

Kither Biotech completes Phase 1 KIT2014 clinical study

Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis

Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study

Precigen and the RRPF recognise International RRP Awareness Day

Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS

GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio

Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis